Arkolith/Insider Trading/NBIO/Form 4

Holden Lowell Thomas

CFO, DirectorNascent Biotech Inc. (NBIO) · full profile →Form 4 · filed Feb 2, 2023
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2023Buy(P)20K$0.14$3K8.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-23-000693) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML